BVCF Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 16

Professionals

  • Investments
  • 70

  • Portfolio
  • 27

  • Exits
  • 35

Exits

BVCF General Information

Company Description

Founded in 2005, BVCF is a venture capital firm based in Shanghai, China. The firm seeks to invest in life sciences and healthcare sectors.

Business Details

Website
www.bvcf.com
Formerly Known As
BioVeda China Fund
Year Founded
2005
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Corporate Office
  • Suite 2604
  • Number 763 Mengzi Road
  • Shanghai, Huangpu 200023
  • China
+86 021

BVCF Investments (70)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Drug Farm 13-Jul-2026 Later Stage VC Drug Discovery Generating Revenue
QiSeLian Biotechnology 18-Apr-2025 Biotechnology Startup
CurePharma 01-Mar-2025 Drug Discovery Generating Revenue
Ealong Biotech 01-Mar-2025 Pharmaceuticals Startup
GenEros 01-Mar-2025 Drug Discovery Generating Revenue
Xinzeyuan 14-Jan-2025 Surgical Devices Generating Revenue
SMT (Medical Supplies) 08-Sep-2023 Medical Supplies Generating Revenue
Seinda 15-Feb-2022 Diagnostic Equipment Generating Revenue/Not Profitable
Oculis Holding 01-Dec-2021 Later Stage VC Drug Discovery Generating Revenue
Cellenkos 04-Nov-2021 Later Stage VC Drug Discovery Clinical Trials - Phase 2
You’re viewing 10 of 70 investments. Get the full list »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BVCF Exits (35)

Company Name Exit Date Exit Type Exit Size
SofMat 28-Apr-2026 Out of Business
Suzhou Ribobio Biotechnology 09-Jan-2026
Oculis Holding 13-Feb-2025
Oculis Holding 28-Feb-2023
Boan Biotech 30-Dec-2022
Biocytogen Pharmaceuticals (Beijing) Co 01-Sep-2022
MicuRx Pharmaceuticals 05-Aug-2022
Clarus Therapeutics 09-Sep-2021
CARsgen Therapeutics 17-Jun-2021 IPO
Allgens 21-May-2021 IPO
You’re viewing 10 of 35 exits. Get the full list »

BVCF Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore BVCF‘s full profile, request access.

Request a free trial

BVCF Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

BVCF Co-Investors (14)

Name With Exits Lead Partner Series Industry
Hanking Family Office 2 Series chart Industry bar
China Construction Bank Series chart Industry bar
Detong Capital Series chart Industry bar
HaoYue Capital Series chart Industry bar
Qiming Venture Partners Series chart Industry bar
You’re viewing 5 of 14 co-investors. Get the full list »

BVCF FAQs

  • What is BVCF?

    Founded in 2005, BVCF is a venture capital firm based in Shanghai, China.

  • When was BVCF founded?

    BVCF was founded in 2005.

  • Where is BVCF headquartered?

    BVCF is headquartered in Shanghai, China.

  • What is BVCF's total asset value?

    BVCF has around in total assets under management.

  • How many investments has BVCF made?

    BVCF has made 70 investments.

  • What has BVCF invested in?

    BVCF has made numerous investments in companies like Drug Farm, QiSeLian Biotechnology, and CurePharma within the Drug Discovery and Biotechnology industries.

  • What has BVCF invested in recently?

    BVCF's latest investment was on 13-Jul-2026 in Drug Farm, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process